Page last updated: 2024-09-05

tolvaptan and Genetic Diseases, X-Chromosome Linked

tolvaptan has been researched along with Genetic Diseases, X-Chromosome Linked in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garrahy, A; Hannon, AM; Thompson, CJ; Williams, DJ; Zia-Ul-Hussnain, HM1
Balla, A; Erdélyi, LS; Groß, U; Hunyady, L; Mann, WA; Morris-Rosendahl, DJ; Nagel, M; Várnai, P1

Other Studies

2 other study(ies) available for tolvaptan and Genetic Diseases, X-Chromosome Linked

ArticleYear
Secondary resistance to tolvaptan in two patients with SIAD due to small cell lung cancer.
    European journal of clinical pharmacology, 2018, Volume: 74, Issue:2

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Resistance; Fatal Outcome; Female; Genetic Diseases, X-Linked; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Sodium; Tolvaptan; Vasopressins

2018
Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis.
    Kidney international, 2015, Volume: 88, Issue:5

    Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arrestins; Benzazepines; beta-Arrestins; Cell Membrane; Cyclic AMP; DNA Mutational Analysis; Dynamins; Endocytosis; Exons; Female; Genetic Diseases, X-Linked; HEK293 Cells; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Mutation; Pedigree; Receptors, Vasopressin; Tolvaptan

2015